Groupmatics: The World of Group Sales Ticketing

July 3, 2014

“Groupmatics is a white-label group ticket platform used by professional sports teams and other public event organizations to manage group sales and collect event attendee data.” This is what is says on the Groupmatics homepage, but I think if you asked their founder and CEO Matt Mastrangelo directly he would just say “We make life […]

Read More...

Zapis Capital Group invests in Westlake software startup Groupmatics

May 28, 2014

Zapis Capital Group has invested a few hundred thousand dollars in a local software company that is helping several sports teams, including the Phoenix Suns of the National Basketball Association, manage their group ticket sales. http://www.crainscleveland.com/article/20140528/FREE/140529819/zapis-capital-group-invests-in-westlake-software-startup-groupmatics

Read More...

Hank McMonigle And Dana Hall Join LDR Interactive’s TopicPulse Management Team

April 2, 2014

LDR INTERACTIVE has hired two new executives to its TOPICPULSE leadership team. HANK MCMONIGLE joins as VP/Sales and DANA HALL joins as Support and Client Services Manager. Read more: http://www.allaccess.com/net-news/archive/story/128411/hank-mcmonigle-and-dana-hall-join-ldr-interactive-#ixzz2xx8Ay51T

Read More...

GenomOncology is searching for a method that sticks

March 9, 2014

A cancer patient’s genome is like a haystack. The gene that caused the cancer is the needle. And Manuel Glynias is selling a huge horseshoe magnet. http://www.crainscleveland.com/article/20140309/SUB1/303099983

Read More...

Agreement sets stage for enhanced My Cancer Genome

February 13, 2014

Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. http://news.vanderbilt.edu/2014/02/agreement-sets-stage-for-enhanced-my-cancer-genome/

Read More...

GenomOncology receives investment from TriStar Technology Ventures

February 5, 2014

http://bit.ly/LFiN08 GenomOncology, a Westlake company that has developed software platforms to automate the analysis of sequenced genetic information, said it has received an investment from TriStar Technology Ventures, a health care innovation venture firm based in Nashville, Tenn.

Read More...

GenomOncology receives investment from TriStar Technology Ventures

February 5, 2014

http://bit.ly/LFiN08 GenomOncology, a Westlake company that has developed software platforms to automate the analysis of sequenced genetic information, said it has received an investment from TriStar Technology Ventures, a health care innovation venture firm based in Nashville, Tenn.

Read More...

LDR Interactive Becomes Futuri Media

February 3, 2014

LDR INTERACTIVE has become FUTURI MEDIA, bolstering its management team with two key appointments. Media and technology industry veteran BRIAN PARSONS has joined FUTURI MEDIA as Chief Information Officer, having served as an EVP for iHEARTMEDIA and TRITON DIGITAL MEDIA. PARSONS and Chief Technology Officer BRIAN SEEDERS, a founding team member, will lead product innovation […]

Read More...

Cleveland Clinic doctor is taking fight vs. disease to heart

January 26, 2014

http://www.crainscleveland.com/article/20140126/SUB1/301269990 “Some of Dr. Hazen’s findings have contributed to the growth of Cleveland HeartLab. It’s a successful Clinic spinoff that now employs 120 people and tests blood samples and other specimens to help doctors determine whether patients are at risk of a heart attack or other medical problems.”

Read More...

Cleveland Clinic doctor is taking fight vs. disease to heart

January 16, 2014

Cleveland Clinic doctor is taking fight vs. disease to heart http://www.crainscleveland.com/article/20140126/SUB1/301269990 “Some of Dr. Hazen’s findings have contributed to the growth of Cleveland HeartLab. It’s a successful Clinic spinoff that now employs 120 people and tests blood samples and other specimens to help doctors determine whether patients are at risk of a heart attack or […]

Read More...